GoodVision AI to Go Public Through Merger with Calisa Acquisition Corp

Reuters explains the U.S. Patriot mobile air defense system, built by Raytheon Technologies, and its PAC-2 and PAC-3 interceptor variants. Demand has risen as Russia’s strikes in Ukraine and the Middle East conflict have depleted interceptor stocks. CSIS estimates about 65% of U.S. interceptors were used Feb-July, leaving under 850. Lockheed received a contract up to $58.6B.

UnitedHealth Group (UNH) said it will commit $4 million via the United Health Foundation to expand the University of Tennessee Health Sciences health hub network from 5 to 13 sites by end-2027, reaching about 200,000 residents. The company reported Q2 revenue of $112B and adjusted EPS of $6.38, raised full-year adjusted EPS guidance to $19.50-$20.

The Wall Street Journal reported Apple is testing memory chips from China’s CXMT across iPhones and MacBooks and has held early talks to supply components for some China-sold devices. Apple is seeking White House approval amid “unsustainable” pricing from SK Hynix, Samsung, Micron and SanDisk. US rules limit customization, but off-the-shelf purchases may be allowed.

AstraZeneca and CSPC Pharmaceutical Group signed a contract to form a joint venture to build a new-generation biologics manufacturing facility in Shijiazhuang, China. The JV will be capitalized 51% by CSPC and 49% by AstraZeneca, subject to regulatory approvals. It will initially make and supply biologics drug substances for global markets.

A federal jury ordered Medtronic’s Covidien unit to pay $88 million to Larry and Tammy Patterson after finding surgeons were not adequately warned about risks of Covidien’s Symbotex hernia mesh. The Aug. 4 verdict followed a three-week trial in Massachusetts. Jurors awarded $77 million to Larry and $11 million for loss of consortium, with no punitive damages.

The article explains the U.S.-made Patriot mobile air defense system and why interceptor missile supplies are down. It cites Raytheon and Lockheed for system details and notes CSIS estimates about 65% of U.S. interceptors were expended Feb to July, leaving under 850. It says the U.S. approved 5,250 interceptors for Gulf states and awarded Lockheed a contract up to $58.6B.